Tesamorelin
Stabilised GHRH analogue.
A stabilised GHRH analogue extensively studied for its effect on visceral adipose tissue and metabolic parameters.
Purity
≥99% (HPLC)
Presentations
10 mg · 30 mg
Format
Research use only
Tesamorelin · RD-12In research terms
How it's
understood.
Stimulates endogenous GH and IGF-1 release; noted in research for a marked effect on visceral (deep abdominal) fat compartments.
Descriptions summarise published research context only. Nothing here is dosing guidance or a claim of any effect in humans.
Where it's studied
Visceral-adiposity models
GH/IGF-1 axis research
Metabolic-parameter studies
Research use only
For laboratory research. Not for human consumption.
Tesamorelin is supplied to researchers and institutions for in-vitro and laboratory study. Need a certificate of analysis or handling detail for Tesamorelin? Get in touch.
Request documentation →Related compounds
View all →
All products listed are supplied strictly for laboratory and research use only. They are not dietary supplements, medicines or foods, and are not intended for human or veterinary consumption, diagnosis or treatment. This website is informational and does not offer products for sale.